The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early-stage breast cancer.
 
Cristina Saura
No Relationships to Disclose
 
Evandro De Azambuja
No Relationships to Disclose
 
Mafalda Oliveira
Research Funding - AstraZeneca
 
Peter Christian Dubsky
No Relationships to Disclose
 
Dimitrios Zardavas
No Relationships to Disclose
 
Christian Fesl
No Relationships to Disclose
 
Aditya Bardia
Consulting or Advisory Role - Novartis
 
Jesus Soberino
No Relationships to Disclose
 
Monica N. Fornier
No Relationships to Disclose
 
Katalin Boer
No Relationships to Disclose
 
Vivian Ng
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Jill O. Fredrickson
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
 
Thomas Stout
Employment - Genentech
Stock and Other Ownership Interests - Exelixis; Roche/Genentech
 
Stina Singel
No Relationships to Disclose
 
Jerry Y. Hsu
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Invivis; Lilly; MSD; Novartis; Pfizer; Radius Health; Roche/Genentech; Synthon
Research Funding - AstraZeneca (Inst); Invivis (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health; Roche/Genentech (Inst); Synthon (Inst)
 
Jose Baselga
Stock and Other Ownership Interests - Apogenix; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma
Consulting or Advisory Role - Infinity Pharmaceuticals; Juno Therapeutics; Lilly; PMV Pharma
Travel, Accommodations, Expenses - Novartis; Roche/Genentech
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; NanoString Technologies; Novartis; Roche/Genentech
Consulting or Advisory Role - Accelsiors; AstraZeneca; Novartis
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; NanoString Technologies; Novartis; Roche/Genentech
Research Funding - GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech; Sanofi; Smiths Medical